Claritev, a leading health data analytics company, has announced a strategic collaboration with Burjeel Holdings, one of the Middle East’s premier healthcare providers. The partnership marks Claritev’s official entry into the Middle Eastern market and underscores a shared commitment to advancing data-driven healthcare across the region.
This long-term collaboration will see the two organizations work closely to develop and deploy data and analytics solutions that support better patient outcomes and drive operational excellence throughout Burjeel’s network of hospitals and clinics.
“We are thrilled to partner with Burjeel and CCRCM a leader in the MENA region’s RCM sector, to combine state-of-the-art technology and services to enhance care, improve healthcare standards, and introduce innovative new solutions to the marketplace,” said Travis Dalton, Chairman, CEO and President of Claritev. “Together, we will leverage our strengths to enhance the healthcare ecosystem, delivering value to providers and payors and prioritizing what matters most – high-quality care for all patients.”
Also Read: Exterro Unveils ExPN: A Unified Partner Network to Drive Sustainable Growth in Data Risk Management
As part of the agreement, Claritev will leverage its expertise in health informatics, predictive modeling, and data strategy to enhance Burjeel’s capabilities in patient care, population health management, and value-based healthcare delivery.
“Burjeel Holdings is committed to advancing healthcare delivery in the region, and this partnership with Claritev increases access to affordable healthcare in MENA,” said John Sunil, Group CEO, Burjeel Holdings. “We believe in the power of collaboration to drive healthcare innovation, and this milestone positions us to deliver unparalleled solutions in healthcare services.”
The alliance positions both companies at the forefront of healthcare innovation in the region, with plans to co-develop scalable solutions that can benefit the broader healthcare ecosystem across the Middle East.
